“I would hope this is a further reflection of the federal government accepting the fact that cannabis may provide certain health benefit to patients in this country,” said Philadelphia-based cannabis attorney Joshua Horn, of Fox Rothschild. “About a year ago, the FDA approved Epidiolex, a drug made from marijuana to treat epilepsy. So one would think this is an extension of that decision.”
Cannabis research: Mississippi ‘ditch weed’ supplier could soon have Pennsylvania competitor – The Philadelphia Inquirer
